Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more

Recent & Breaking News (NYSE:QGEN)

QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus

GlobeNewswire October 4, 2023

QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness

GlobeNewswire September 28, 2023

QIAGEN reports progress toward achieving Environmental, Social and Governance goals in 2022 Sustainability Report

GlobeNewswire September 27, 2023

QIAGEN enhances QIAwave portfolio with new eco-friendlier nucleic acid extraction kits

GlobeNewswire September 25, 2023

QIAGEN delivers ahead of outlook for Q2 2023 with 9% CER sales growth in non-COVID products and updates 2023 full-year outlook

GlobeNewswire August 8, 2023

QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines' AYVAKIT® (avapritinib) in gastrointestinal stromal tumors

GlobeNewswire August 7, 2023

Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement

GlobeNewswire July 26, 2023

QIAGEN N.V. to release results for Q2 2023 and hold webcast

GlobeNewswire July 24, 2023

QIAGEN expands range of digital PCR kits and services for the biopharma industry

GlobeNewswire July 18, 2023

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)

GlobeNewswire June 20, 2023

QIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes

GlobeNewswire June 16, 2023

QIAGEN's QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening

GlobeNewswire June 15, 2023

Danish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing

GlobeNewswire June 13, 2023

QIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth in non-COVID product portfolio

GlobeNewswire May 3, 2023

QIAGEN welcomes U.S. Preventive Services Task Force reaffirmation for latent TB screening in populations at increased risk

GlobeNewswire May 3, 2023

QIAGEN launches QIAstat-Dx in Japan with respiratory panel for syndromic testing

GlobeNewswire April 24, 2023

QIAGEN announces expansion of Supervisory Board

GlobeNewswire April 20, 2023

QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023

GlobeNewswire April 14, 2023

QIAGEN's QIAxcel Connect wins Red Dot design award

GlobeNewswire March 29, 2023

QIAGEN receives approval for its net-zero carbon emissions target by Science Based Targets initiative (SBTi)

GlobeNewswire March 27, 2023